Cas:133407-83-7 Z-Leu-Leu-Nle-aldehyde manufacturer & supplier

We serve Chemical Name:Z-Leu-Leu-Nle-aldehyde CAS:133407-83-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Z-Leu-Leu-Nle-aldehyde

Chemical Name:Z-Leu-Leu-Nle-aldehyde
CAS.NO:133407-83-7
Synonyms:Z-Leu-Leu-Nle-H;benzyl N-[(2S)-4-methyl-1-[[(2S)-4-methyl-1-oxo-1-[[(2S)-1-oxohexan-2-yl]amino]pentan-2-yl]amino]-1-oxopentan-2-yl]carbamate;IN1097;Z*Leu-Leu-Nle-CHO;Z-Leu-Leu-Nle-aldehyde
Molecular Formula:C26H41N3O5
Molecular Weight:475.62100
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:113.60000
Exact Mass:475.30500
LogP:4.90500

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Z-Leu-Leu-Nle-H chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Z-Leu-Leu-Nle-aldehyde physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Z-Leu-Leu-Nle-H Use and application,Z-Leu-Leu-Nle-aldehyde technical grade,usp/ep/jp grade.


Related News: Some experts have criticised the ministry’s analysis because of possible bias that could be skewing the data. Others said Israel should wait a little longer to receive more information about the safety and effectiveness of a third shot. read more N,N-Diphenyl-hydroxylamino-(1,3,5-tri-tert-butyl-4-oxo-cyclohexa-2,5-dienyl)-ether manufacturers Earlier this year, the company revealed it had broken ground on a 38,000-square-foot commercial cell therapy plant in Lexington, Massachusetts, which is about 10 miles from downtown Boston. Takeda says the new $84 million plant will be used to make cell therapies for cancers and other diseases. O-Methyl-S-(2-ethylthio-1-methoxymethyl)-ethyl-phosphorthioamidat suppliers The company forecasts that the 70-strong team will grow by around 50% in the next three years to support its clinical and commercial API manufacturing capabilities. [(η(5)-C5Me5)RuCl(μ2-SiPr)2Ru(CO)(η(5)-C5Me5)]OSO2CF3 vendor & factory.